James G. Stout
Keine laufenden Positionen mehr
Profil
James G.
Stout worked as the Director of Purification Sciences at Amgen, Inc. from 2006 to 2010.
He then served as the Director of Process Science & Engineering at ImmunoGen, Inc. in 2012.
Prior to that, he was the Associate Director of Purification Development at Medarex, Inc. from 2001 to 2002.
James also held the position of Associate Director of Process Development at Shire US, Inc. He later became the Associate Director of Purification Process at Shire Human Genetic Therapies, Inc. from 2010 to 2012.
In 2018, he worked as the Director of Process Science Biologics at BioVectra, Inc. USA. James also worked as a Principal Scientist at Alexion Pharmaceuticals, Inc. He served as the Vice President of Process Sciences at Natrix Separations, Inc. from 2012 to 2017.
Additionally, he was the Group Leader of Purification Process Sciences at AbbVie Bioresearch Center, Inc. James held the position of Vice President of Glycobiologic Process Development at HOST Therabiomics from 2017 to 2018.
Currently, he is the Vice President of Chemistry, Manufacturing & Controls at Shattuck Labs, Inc. from 2020 to 2023.
Dr. Stout completed his undergraduate degree at Denison University.
He then pursued a doctorate degree at the University of Cincinnati (Ohio).
Ehemalige bekannte Positionen von James G. Stout
| Unternehmen | Position | Ende |
|---|---|---|
| SHATTUCK LABS, INC. | Corporate Officer/Principal | 02.10.2023 |
BioVectra, Inc. USA
 BioVectra, Inc. USA Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, BioVectra, Inc. USA is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Charlottetown, CA. | Corporate Officer/Principal | 01.12.2019 |
HOST Therabiomics
 HOST Therabiomics BiotechnologyHealth Technology HOST Therabiomics operates as a microbiome-based therapeutics firm. It focused on introducing specific beneficial bacterial species or other compounds to the gut, mouth, or skin to try and restore health. The company is headquartered in St Helier, the United Kingdom. | Corporate Officer/Principal | 01.03.2018 |
NATRIX Separations, Inc.
 NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Corporate Officer/Principal | 01.11.2017 |
| IMMUNOGEN, INC. | Chief Tech/Sci/R&D Officer | 01.11.2012 |
Ausbildung von James G. Stout
| Denison University | Undergraduate Degree |
| University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| IMMUNOGEN, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Distribution Services |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Health Technology |
| AbbVie Bioresearch Center, Inc. | |
BioVectra, Inc. USA
BioVectra, Inc. USA Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, BioVectra, Inc. USA is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Charlottetown, CA. | Health Technology |
HOST Therabiomics
HOST Therabiomics BiotechnologyHealth Technology HOST Therabiomics operates as a microbiome-based therapeutics firm. It focused on introducing specific beneficial bacterial species or other compounds to the gut, mouth, or skin to try and restore health. The company is headquartered in St Helier, the United Kingdom. | Health Technology |
